Peter Hayward, Editor-in-Chief of The Lancet HIV, speaks to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.
Read the full article:
The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.
Read the full article:
The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa.
Read the full article:
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.
Read the PopART trial papers:
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.
Read the full Review:
HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.
Read the full article:
A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B.
Read the full article:
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.
Read the full article:
Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.
Read the full article:
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV.
Read the Series:
Ageing with HIV
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00049-7/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30358-1/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30340-4/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30302-7/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Adam Castillejo joins The Lancet HIV’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deputy Editor Philippa Harris discusses viral load testing with Paul Drain (University of Washington, USA) and a trial of point-of-care testing with task shifting to improve treatment outcomes.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Joseph Kagaayi (Rakai Health Sciences Program, Uganda) and Oliver Ratman (Imperial College London, UK) talk to Editor-in-Chief Peter Hayward about the world famous research site and the insights that deep sequencing has provided into the flow of HIV in their latest research.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Marta Nunes (University of the Witwatersrand, Johannesburg, South Africa) talks to Philippa Harris about vaccination response in people living with HIV and a trial of influenza vaccine dosing in pregnant women with HIV in South Africa.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
For World AIDS day, The Lancet HIV Deputy Editor Philippa Harris talks to Jeff Lazarus and Nikos Dedes about the importance of good health-related quality of life and the barriers people living with HIV face in achieving this.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Giuseppe Pantaleo (Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Switzerland) tells Peter Hayward about a phase 1 vaccine study published in the November issue of The Lancet HIV, and gives an overview of the HIV vaccine field.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Julia Marcus and Douglas Krakower talk to Peter Hayward about the use of electronic health record data to predict HIV risk and identify PrEP candidates.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet HIV Deputy Editor Philippa Harris talks to Betsy Herold (Albert Einstein College of Medicine, USA) about her trial investigating a tenofovir disoproxil fumarate intravaginal ring for pre-exposure prophylaxis in sexually active women.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Sheree Schwartz (Johns Hopkins School of Public Health) talks to The Lancet HIV Editor-in-Chief Peter Hayward about the Sakh'umndeni Safer Conception Project safer conception project for South African couples living with HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Sunil Solomon (Johns Hopkins School of Medicine, USA) discusses the trials and tribulations of investigating integrated HIV testing, prevention, and treatment centres for people who inject drugs and men who have sex with men in India.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet HIV Editor Peter Hayward talks to Evgeny Krupitsky about a trial investigating the potential of slow-release naltrexone to improve HIV treatment adherence in drug users in St Petersburg.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet HIV Deputy Editor Liz Zuccala joins Stephanie Cohen to discuss a case report of an individual who acquired HIV despite reporting good adherence to PrEP.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
For World AIDS Day we explore how, despite huge advances, children are affected by HIV in 2018. We speak to Martina Penazzato of WHO on drug options and development, to Mark Cotton (Stellenbosch University) on the course of HIV management from infancy to adolescents (12 min 03), and to Tamsen Rochat (Human Sciences Research Council in South Africa) on how HIV still impacts the lives of children who don’t have the virus (26 min 33).
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Andrew Grulich joins The Lancet HIV editor-in-chief Peter Hayward to discuss the EPIC-NSW study, looking at the population-level effectiveness of PrEP in New South Wales, Australia.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward and Gregg Gonsalves discuss a new modelling study looking at an outbreak of HIV in Scott County, Indiana, USA.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward, editor-in-chief of The Lancet HIV, talks to Sanne van Luenen about her recent work on a new intervention for individuals with HIV and depressive symptoms.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Frances Mary Cowan, an author of the SAPPHI-IRe trial, talks to The Lancet HIV about efforts to improve HIV services for this key population in Zimbabwe.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Geoffrey Gottlieb and Robert Smith talk with The Lancet HIV about enhancing care and clinical management of patients infected with HIV-2.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Manon Ragonnet-Cronin joins The Lancet HIV Editor, Peter Hayward, to discuss the use of phylogenetic analysis to gain insight into HIV transmission in the UK, the potential role of non-disclosed MSM, and targeting of HIV interventions.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Editor-in-Chief of The Lancet HIV Peter Hayward discusses the new look journal and talks to Louise Kuhn, an author of the journal's first Review, about the opportunities and possibilities of starting antiretroviral therapy soon after birth in infants with HIV.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Francois Dabis discusses his paper on universal test and treat and the HIV epidemic in rural South Africa.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Linda-Gail Bekker discusses her trial of the feasibility of non-daily pre-exposure prophylaxis dosing on African women.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Steven Goodreau and Eli Rosenberg explain their modelling of the causes of disparities in HIV incidence among black and white men who have sex with men in Atlanta, GA, USA.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Beatriz Grinsztejn discusses the prevalence of HIV among transgender women in Rio de Janeiro, Brazil.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Audio discussion of developments in the HIV field with three leading experts.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
